TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 5, 2011, Pages

  Salerno, Paolo ^a   Garcia Rostan, Ginesa ^b,c   Piccinin, Sara ^d   Bencivenga, Tammaro Claudio ^a   Di Maro, Gennaro ^a   Doglioni, Claudio ^e   Basolo, Fulvio ^f   Maestro, Roberta ^d   Fusco, Alfredo ^a   Santoro, Massimo ^a   Salvatore, Giuliana ^g  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PORTO   (Portugal)

^c Universidad de Valladolid y Consejo Superior de Investigaciones Científicas   (Spain)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f UNIVERSITY OF PISA   (Italy)

^g UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; RNA; STAUROSPORINE; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG;

ANAPLASTIC THYROID CARCINOMA; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INVASION; CANCER RESISTANCE; CANCER TISSUE; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PATHOPHYSIOLOGY; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; THYROID CARCINOMA; TUMOR DIFFERENTIATION; UPREGULATION;

APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, NEOPLASM; THYROID NEOPLASMS; TRANSFECTION; TUBULIN; TWIST TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 79955651656     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1182     Document Type: Article

References (36)

1. Kondo T, Ezzat S, Asa SL 2006 Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6:292-306
2. Fagin JA, MitsiadesN2008 Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Pract Res Clin Endocrinol Metab 22:955-969
3. Smallridge RC, Marlow LA, Copland JA 2009 Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer 16:17-44
4. Ringel MD 2009 Molecular markers of aggressiveness of thyroid cancer. Curr Opin Endocrinol Diabetes Obes 16:361-366
5. Nikiforov YE 2004 Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocr Pathol 15:319-327 (Pubitemid 40208912)
6. García-Rostán G, Costa AM, Pereira-Castro I, Salvatore G, Hernandez R, Hermsem MJ, Herrero A, Fusco A, Cameselle-Teijeiro J, Santoro M 2005 Mutation of the PIK3CA gene in anaplastic thyroid cancer. Cancer Res 65:10199-10207 (Pubitemid 41743711)
7. Wu G, Mambo E, Guo Z, Hu S, Huang X, Gollin SM, Trink B, Ladenson PW, Sidransky D, Xing M 2005 Uncommon mutation, but common amplifications, of the PIK3CA gene in thyroid tumors. J Clin Endocrinol Metab 90:4688-4693 (Pubitemid 41159359)
8. Malaguarnera R, Vella V, Vigneri R, Frasca F 2007 p53 family proteins in thyroid cancer. Endocr Relat Cancer 14:43-60 (Pubitemid 47521721)
9. Salvatore G, Nappi TC, Salerno P, Jiang Y, Garbi C, Ugolini C, Miccoli P, Basolo F, Castellone MD, Cirafici AM, Melillo RM, Fusco A, Bittner ML, Santoro M 2007 A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. Cancer Res 67:10148-10158 (Pubitemid 350070786)
10. Chen ZF, Behringer RR 1995 Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 9:686-699
11. Thisse B, el Messal M, Perrin-Schmitt F 1987 The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic Acids Res 15:3439-3453
12. el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D, Bourgeois P, Bolcato-Bellemin AL, Munnich A, Bonaventure J 1997 Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 15:42-46
13. Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH, Hannon GJ 1999 Twist is a potential oncogene that inhibits apoptosis. Genes Dev 13:2207-2217
14. Puisieux A, Valsesia-Wittmann S, Ansieau S 2006 A twist for survival and cancer progression. Br J Cancer 94:13-17 (Pubitemid 43088534)
15. Valsesia-Wittmann S, Magdeleine M, Dupasquier S, Garin E, Jallas AC, Combaret V, Krause A, Leissner P, Puisieux A 2004 Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell 6:625-630 (Pubitemid 40017705)
16. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA 2004 Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927-939 (Pubitemid 38798858)
17. Kalluri R, Weinberg RA 2009 The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420-1428
18. Wang X, Ling MT, Guan XY, Tsao SW, Cheung HW, Lee DT, Wong YC 2004 Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene 23:474-482 (Pubitemid 38175002)
19. Li J, Wood 3rd WH, Becker KG, Weeraratna AT, Morin PJ 2007 Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells. Oncogene 26:2860-2872 (Pubitemid 46701436)
20. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S, Maestro R, Voeltzel T, Selmi A, Valsesia-Wittmann S, Caron de Fromentel C, Puisieux A 2008 Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14:79-89
21. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC, Haugen BR 2008 Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 93: 4331-4341 (Pubitemid 352789529)
22. Salerno P, De Falco V, Tamburrino A, Nappi TC, Vecchio G, Schweppe RE, Bollag G, Santoro M, Salvatore G 2010 Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells. J Clin Endocrinol Metab 95:450-455
23. Curcio F, Ambesi-Impiombato FS, Perrella G, Coon HG 1994 Longterm culture and functional characterization of follicular cells from adult normal human thyroids. Proc Natl Acad Sci USA 91:9004-9008
24. Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M, Vecchio G 1987 One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol Cell Biol 7:3365-3370
25. Melillo RM, Castellone MD, Guarino V, De Falco V, Cirafici AM, Salvatore G, Caiazzo F, Basolo F, Giannini R, Kruhoffer M, Orntoft T, Fusco A, Santoro M 2005 The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest 115:1068-1081 (Pubitemid 40489412)
26. Hedinger C, Williams ED, Sobin LH 1989 The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908-911 (Pubitemid 19063200)
27. DeLellis RA, Lloyd R, Heitz PU 2004 WHOclassification of tumors: pathology and genetics of tumors of endocrine organs. Lyon, France: IARC Press
28. Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J 2007 Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256-1264 (Pubitemid 47207131)
29. Demontis S, Rigo C, Piccinin S, Mizzau M, Sonego M, Fabris M, Brancolini C, Maestro R 2006 Twist is substrate for caspase cleavage and proteasome-mediated degradation. Cell Death Differ 13: 335-345 (Pubitemid 43102216)
30. Ansieau S, Morel AP, Hinkal G, Bastid J, Puisieux A 2010 TWISTing an embryonic transcription factor into an oncoprotein. Oncogene 29:3173-3184
31. Reinhold MI, Kapadia RM, Liao Z, Naski MC 2006 The Wntinducible transcription factor TWIST1 inhibits chondrogenesis. J Biol Chem 281:1381-1388
32. Dupont J, Fernandez AM, Glackin CA, Helman L, LeRoith D 2001 Insulin-like growth factor 1 (IGF-1)-induced twist expression is involved in the anti-apoptotic effects of the IGF-1 receptor. J Biol Chem 276:26699-26707
33. Pham CG, Bubici C, Zazzeroni F, Knabb JR, Papa S, Kuntzen C, Franzoso G 2007 Upregulation of Twist-1 by NF-κB blocks cytotoxicity induced by chemotherapeutic drugs. Mol Cell Biol 27: 3920-3935 (Pubitemid 47010991)
34. Garcia-Rostan G, Tallini G, Herrero A, D'Aquila TG, Carcangiu ML, Rimm DL 1999 Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma. Cancer Res 59:1811-1815 (Pubitemid 29186147)
35. Pacifico F, Leonardi A 2010 Role of NF-κB in thyroid cancer. Mol Cell Endocrinol 321:29-35
36. Zhang X, Wang Q, Ling MT, Wong YC, Leung SC, Wang X 2007 Anti-apoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells. Int J Cancer 120:1891-1898 (Pubitemid 46418364)